From our first patient in January 2004, a thoroughbred race horse named Xpress Xcess, to the 32 new patients that were treated in July, VetStem has reached a milestone: over 14,000 patients have been treated with VetStem Regenerative Cell Therapy!

As the first company to provide adipose-derived stem cell services to veterinarians across the United States and Canada, VetStem has been a leader in the field of regenerative veterinary medicine for over a decade.  Through peer-reviewed studies, multiple case reports, and numerous success stories, VetStem Regenerative Cell Therapy has been shown to be an effective treatment for arthritis as well as tendon and ligament injuries.

The VetStem team works hard to remain relevant and reputable.  We take pride in our strict procedures and protocols, which are guided by FDA regulations.  Our R&D and Clinical Development teams work tirelessly to research new uses for stem cells and create new stem cell protocols.

VetStem continues to contribute to the growth of the rapidly developing regenerative medicine market.  We would not be where we are today without the nearly 2,500 veterinarians and over 10,000 dog, cat, and horse owners who have entrusted us with their patient’s and their animal’s stem cells.  For that, we thank you!